Serum leptin and vascular risk factors in obstructive sleep apnea - PubMed (original) (raw)

Comparative Study

Serum leptin and vascular risk factors in obstructive sleep apnea

M S Ip et al. Chest. 2000 Sep.

Abstract

Study objectives: To define the metabolic profile relevant to vascular risks in obstructive sleep apnea (OSA) and the role of leptin resistance in this risk profile.

Design: Case control study.

Setting: Sleep Laboratory, Queen Mary Hospital, University of Hong Kong, China.

Methods: Thirty OSA subjects were matched with 30 non-OSA subjects for body mass index (BMI), age, sex, and menopausal status. Neck, waist, and hip girth, skinfold thickness, and fasting serum levels of lipids, glucose, insulin, and leptin were compared between these two groups.

Results: Compared with control subjects with a similar BMI but without OSA, the OSA group had a significantly more adverse vascular risk factor profile, including dyslipidemia, higher diastolic BP, insulin resistance, and greater adiposity reflected by skinfold thickness. OSA subjects also had higher circulating leptin levels (9.18+/-4.24 ng/mL vs 6.54+/-3.81 ng/mL, mean +/- SD, p = 0.001). Serum leptin levels correlated positively with BMI, skinfold thickness, serum cholesterol, low-density lipoprotein cholesterol, insulin, insulin/glucose ratio, apnea-hypopnea index, and oxygen desaturation time; multiple stepwise regression analysis identified skinfold thickness, waist/hip ratio, serum low-density lipoprotein cholesterol, and diastolic BP as independent correlates, while only serum insulin and diastolic BP were independent correlates in OSA subjects. After treatment with nasal continuous positive airway pressure for 6 months, there was a significant decrease in circulating leptin (p = 0.01) and triglyceride levels (p = 0.02) without change in other parameters.

Conclusion: Despite controlling for BMI, OSA subjects showed distinct profiles with clustering of vascular risk factors. Hyperleptinemia was present in the OSA subjects, but it can be normalized by treatment with nasal continuous positive airway pressure, suggesting that increased leptin resistance was not the cause of OSA or its associated vascular risks.

PubMed Disclaimer

Comment in

Leptin, obesity, and obstructive sleep apnea.
Marik PE. Marik PE. Chest. 2000 Sep;118(3):569-71. doi: 10.1378/chest.118.3.569. Chest. 2000. PMID: 10988169 Review. No abstract available.

Cited by

Caloric restriction prevents obesity- and intermittent hypoxia-induced cardiac remodeling in leptin-deficient ob/ob mice.
Jones AA, Framnes-DeBoer SN, Shipp A, Arble DM. Jones AA, et al. Front Physiol. 2022 Sep 8;13:963762. doi: 10.3389/fphys.2022.963762. eCollection 2022. Front Physiol. 2022. PMID: 36160851 Free PMC article.
Obstructive Sleep Apnoea and Hypertension: the Role of the Central Nervous System.
Henderson LA, Macefield VG. Henderson LA, et al. Curr Hypertens Rep. 2016 Jul;18(7):59. doi: 10.1007/s11906-016-0665-2. Curr Hypertens Rep. 2016. PMID: 27278369 Review.
Short Hypoxia Does not Affect Plasma Leptin in Healthy Men under Euglycemic Clamp Conditions.
Schmoller A, Voss M, Gehring H, Rudolf S, Schweiger U, Schultes B, Oltmanns KM. Schmoller A, et al. Int J Endocrinol. 2009;2009:270698. doi: 10.1155/2009/270698. Epub 2009 Jun 1. Int J Endocrinol. 2009. PMID: 19946426 Free PMC article.
Leptin and Asthma: What Are the Interactive Correlations?
Wang Y, Hu C. Wang Y, et al. Biomolecules. 2022 Nov 29;12(12):1780. doi: 10.3390/biom12121780. Biomolecules. 2022. PMID: 36551211 Free PMC article. Review.
Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea.
Kapsimalis F, Varouchakis G, Manousaki A, Daskas S, Nikita D, Kryger M, Gourgoulianis K. Kapsimalis F, et al. Lung. 2008 Jul-Aug;186(4):209-217. doi: 10.1007/s00408-008-9082-x. Epub 2008 Mar 26. Lung. 2008. PMID: 18365276

Serum leptin and vascular risk factors in obstructive sleep apnea - PubMed (original) (raw)